SecBot SecBot
8-K ·Filed Oct 30, 2026

ABOS

Acumen Pharmaceuticals, Inc.
BEARISH
Impact 7/10
Processed54m ago SEC0001628280-26-068425
8-K context-dependent: Items 7.01, 8.01

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-068425
Document: abos-20261030xexx991.htm0001628280-26-068425
Document: 0001628280-26-068425-index-headers.html0001628280-26-068425
Document: 0001628280-26-068425-index.html0001628280-26-068425
Document: 0001628280-26-068425.txt0001628280-26-068425
20 reports for ABOS
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ABOS, sortable and filterable
TypeNow
Oct 30, 2026
today
8-K
BEARISH ★ 7/10
$0.6898awaiting T+1awaiting T+1$2.29 (−231.98%)
Oct 30, 2026
today
Press Release
BEARISH ★ 9/10
$1.67awaiting T+1awaiting T+1$2.29 (−37.54%)
Oct 29, 2026
1d ago
EFFECT
NEUTRAL ★ 3/10
$2.40awaiting T+1awaiting T+1$2.29 (−4.58%)
Oct 26, 2026
3d ago
S-3
BEARISH ★ 5/10
$2.26 $2.38▼ −5.31%▼ −4.97%$2.29 (−1.33%)
Oct 26, 2026
4d ago
8-K
NEUTRAL ★ 6/10
No priceawaiting T+1awaiting T+1No price
Oct 26, 2026
4d ago
Press Release
NEUTRAL ★ 5/10
$2.27 $2.26▼ −0.44%▼ −1.00%$2.29 (+0.88%)
Oct 22, 2026
8d ago
Press Release
NEUTRAL ★ 3/10
$2.06 $1.98▼ −3.88%▼ −3.36%$2.29 (+11.17%)
Oct 19, 2026
10d ago
Press Release
NEUTRAL ★ 1/10
$2.02 $2.03▲ +0.74%▲ +0.22%$2.29 (+13.65%)
Sep 16, 2026
6w ago
8-K
NEUTRAL ★ 3/10
$2.61 $2.57▼ −1.53%▼ −2.67%$2.29 (−12.26%)
Aug 12, 2026
11w ago
Institutional Cluster
NEUTRAL ★ 4/10
$2.51 $2.55▲ +1.59%▲ +0.90%$2.29 (−8.76%)
Showing 10 of 20

US Market Status

Market Closed · Opens in 1h 28m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 30, 2026

Fresh ABOS Intelligence

Analysis is for subscribers only.

Subscribe for Full Access